http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102233266-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-32 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 |
filingDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102233266-B1 |
titleOfInvention | Compositions for prevention or treatment of Helicobacter pylori infection comprising cytidylic acid, adenylic acid or its salt as active ingredient |
abstract | The present invention relates to a pharmaceutical composition or a health functional food composition for the prevention or treatment of Helicobacter pylori infection using cytidylic acid, adenylic acid or a salt thereof as an active ingredient, and the cytidylic acid, adenylic acid or salt thereof of the present invention, or a salt thereof The yeast extract containing is significantly superior to glycomacropeptide or N-acetylneuraminic acid, so it has an activity for preventing or treating Helicobacter pylori infection, so it can be usefully used as a pharmaceutical composition or a health functional food composition for preventing or treating Helicobacter pylori infection. |
priorityDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 268.